Document is current
Any future updates will be listed below
-
Authors
Shrode, Rachel L.
Knobbe, Jessica E.
Cady, Nicole
Yadav, Meeta
Hoang, Jemmie
Cherwin, Catherine
Curry, Melissa
Garje, Rohan
Vikas, Praveen
Sugg, Sonia
Phadke, Sneha
Filardo, Edward
Mangalam, Ashutosh K. https://orcid.org/0000-0002-9926-2531
-
Funding
Funding for this research was provided by:
Informatics Fellowship from the University of Iowa
National Institutes of Health (T32 GM139776)
National Cancer Institute/Nation Institute of Health (P30CA086862)
National Institutes of Health/NIAID (1RO1AI137075)
Veteran Affairs Merit Award (1I01CX002212)
NIEHS/NIH P30 (ES005605)
Gift from P. Heppelmann and M. Wacek
Carver Trust Pilot Gran
Pilot award from Center for Biocatalysis and Bioprocessing
- License Information
-
More Information
Article History
Received: 18 October 2022
Accepted: 2 January 2023
First Online: 11 January 2023
Competing interests
: A.K.M. is one of the inventors of a technology claiming the use of <i>Prevotella histicola</i> to treat autoimmune diseases. A.K.M. received royalties from Mayo Clinic (paid by Evelo Biosciences). However, no fund or product from the patent were used in the present study. All other authors declare no commercial or financial relationships that could be a potential conflict of interest.
